The proteasome is the most complex, important, and intricately regulated protease in nature. When substrates dock onto the proteasome they may undergo a variety of fates in addition to being degraded. Ubiquitin may be removed from the substrate before degradation is initiated, pre-empting degradation. Alternatively, preexisting chains on the substrate may be extended to promote degradation. Some substrate-bound chains can also shut down or slow proteasome activity, through manipulating its conformational state. Chain editing factors also regulate the processivity of the proteasome. In addition, substrate recognition can be mediated by any of six distinct proteasome-associated ubiquitin receptors. These systems were originally revealed mainly in yeast, by us and by other groups, but are conserved in eukaryotes and now understood to be relevant to significant diseases, including cancer and ALS. In this proposal we attempt to define the underlying rules of these editing processes as well as the specific sites in the proteasome that are critical for chain binding and editing. There are two distinct pathways by which a key chain-disassembling factor of the proteasome, USP14, is activated, and both are now defined genetically. One pathway provides for control via AKT-dependent signaling pathways, the other for control by the proteasome. Both pathways will be explored here. Remarkably we have found that the machinery for the activation of Ubp6 (the yeast ortholog of USP14) is identical to that for a substrate- and Ubp6-dependent inhibition of the proteasome itself that we previously reported. This linchpin thus provides for reciprocal regulation between Ubp6 and the proteasome. We will try to achieve deeper insights in these unique pathways by combining genetics, biochemistry, structural biology, and proteomics. We will also investigate USP14/Ubp6 substrate specificity, which, according to our recent work, is completely novel, as these enzymes show a dramatic preference for substrates modified by more than one ubiquitin chain. Another powerful regulator of substrate turnover is Hul5 (whose mammalian ortholog is UBE3C), a ligase that we found to be associated with the proteasome. Hul5 is important for stress resistance and is thought to act by extending proteasome-bound ubiquitin chains. We will identify favored substrates of Hul5 and UBE3C by proteomics and use these to address mechanistic models for these enzymes. We will also clarify the physiology of UBE3C and its close paralog UBE3B, which have both been linked to human disease, and attempt to explain their physiology in terms of specific ubiquitination events. Finally, to better understand how the proteasome processes ubiquitin chains we will address ubiquitin chain recognition itself, a very complex process involving to date at least six distinct receptors. Mutations in these receptors can cause ALS and have been implicated in Alzheimer?s disease. We will search for new proteasomal ubiquitin receptors whose existence is implied by our genetic data, and also investigate the relationship between the ?intrinsic ubiquitin receptors,? which are proteasome subunits, and the ?shuttle factors? that deliver ubiquitin to the proteasome.

Public Health Relevance

(Relevance Statement) The proteasome is the most important protease in all of nature, and exerts regulatory effects over many aspects of the biology of the cell. Our proposal is to investigate a small set of key proteasome regulators, several of which have been implicated in human disease. Our work may provide new insights in neurodegenerative disease, cancer, and developmental disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM043601-25
Application #
9406132
Study Section
Membrane Biology and Protein Processing Study Section (MBPP)
Program Officer
Gindhart, Joseph G
Project Start
1989-12-01
Project End
2020-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
25
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Harvard Medical School
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Li, Frances; Tian, Geng; Langager, Deanna et al. (2017) Nucleotide-dependent switch in proteasome assembly mediated by the Nas6 chaperone. Proc Natl Acad Sci U S A 114:1548-1553
Boselli, Monica; Lee, Byung-Hoon; Robert, Jessica et al. (2017) An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons. J Biol Chem 292:19209-19225
de Poot, Stefanie A H; Tian, Geng; Finley, Daniel (2017) Meddling with Fate: The Proteasomal Deubiquitinating Enzymes. J Mol Biol 429:3525-3545
Finley, Daniel; Chen, Xiang; Walters, Kylie J (2016) Gates, Channels, and Switches: Elements of the Proteasome Machine. Trends Biochem Sci 41:77-93
Choi, Won Hoon; de Poot, Stefanie A H; Lee, Jung Hoon et al. (2016) Open-gate mutants of the mammalian proteasome show enhanced ubiquitin-conjugate degradation. Nat Commun 7:10963
Luan, Bai; Huang, Xiuliang; Wu, Jianping et al. (2016) Structure of an endogenous yeast 26S proteasome reveals two major conformational states. Proc Natl Acad Sci U S A 113:2642-7
Rose, Christopher M; Isasa, Marta; Ordureau, Alban et al. (2016) Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst 3:395-403.e4
Shi, Yuan; Chen, Xiang; Elsasser, Suzanne et al. (2016) Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome. Science 351:
Lee, Byung-Hoon; Lu, Ying; Prado, Miguel A et al. (2016) USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites. Nature 532:398-401
Chen, Shuobing; Wu, Jiayi; Lu, Ying et al. (2016) Structural basis for dynamic regulation of the human 26S proteasome. Proc Natl Acad Sci U S A 113:12991-12996

Showing the most recent 10 out of 47 publications